期刊名称：NEUROPHARMACOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Neuropharmacology publishes monthly articles of any length (full papers, rapid communications and reviews) that fall within the discipline of neuroscience. Papers within the area of cellular and molecular neuroscience and/or that contain a significant neuropharmacological content are particularly encouraged.
Papers will only be considered for publication providing they make an original and important contribution to the field of neuropharmacology. Submission to this journal is taken to imply that manuscripts have not been, and will not be submitted elsewhere until a decision has been made by the editor of Neuropharmacology. |
|
Abstracting / Indexing
- BIOSIS
- Chemical Abstracts
- Current Contents/ISI/BIOMED Database
- Current Contents/Life Sciences
- Current Contents/SciSearch Database
- Current Contents/Science Citatation Index
- EMBASE
|
- Elsevier BIOBASE
- Index Medicus
- Medline
- PASCAL/CNRS
- Psychology Abstracts
- Research Alert
|
Instructions to Authors
Type of manuscript
Research Papers. Full papers can be of any length. However, authors should be as succinct as possible and excessively verbose manuscripts may be returned without review.
Mini-Reviews. Short, timely reviews will be by invitation. However suggestions for reviews are most welcome, and should be sent to the Chief Editor.
Online submission of papers
It is now possible to submit your manuscript to the Neuropharmacology Editorial office electronically.
Before submitting, it is essential that you refer to the Elsevier Artwork Guidelines: http://www.elsevier.com/locate/authorartwork
Once you are ready to submit:
1. Select 'Submit online to this journal' option from the 'Journal Services' on the 'Author Gateway'.
2. Follow prompts online. Please note that at each stage of the submission process it is possible to go back a step, save the submission to continue later or remove/change any information already entered.
3. The submission tool will generate a PDF file to be used for the reviewing process.
4. You will receive confirmation of your submission, and further progress of your paper at every stage of its review period thereafter, via e-mail.
Hardcopy Submission of papers
The original and three high quality copies of the manuscript should be sent to: Neuropharmacology, Editorial Office, University of Bristol, Bristol, BS8 1TD, U.K. [Tel. +44 (0) 117 928 8085; Fax +44 (0) 117 928 7405; E-mail editor-neuropharmacology@bristol.ac.uk.].
Do not include a disk with the first submission.
An accompanying letter should indicate the number of pages, figures and tables in the manuscript, and may suggest an appropriate Editor for handling the paper. Manuscripts and figures will not be returned unless specifically requested, and will be discarded one month after publication.
Submission of final accepted paper
Authors are requested to submit a computer disk (5.25 or 3.5 HD/DD disk) containing the final version of the papers along with the final manuscript to the editorial office. Please observe the following criteria:
1. When your paper has been refereed, revised if necessary and accepted, send a disk containing the final version with the final hard copy. Make sure that the disk and the hard copy match exactly.
2. Specify what software was used, including which release, e.g. WordPerfect 5.1.
3. Specify what computer was used (either IBM-compatible PC or Apple Macintosh).
4. Include the text file and separate table and illustration files, if available.
5. The file should follow the general instructions on style/arrangement and, in particular, the reference style of this journal as given in the Instructions to Authors.
6. The file should be single-spaced and should use the wrap-around end-of-line feature, i.e. no returns at the end of each line. All textual elements should begin flush left; no paragraph indents. Place two returns after every element such as title, headings, paragraphs, figure and table call-outs.
7. Keep a back-up disk for reference and safety.
Transfer of Copyright
Elsevier will mail the corresponding author a "Transfer of Copyright" agreement once the paper has been received in production. All authors must sign the agreement before the article can be published. This transfer agreement enables Elsevier Ltd to protect the copyrighted material for the authors, but does not relinquish the author's proprietary rights. The copyright transfer covers the exclusive rights to reproduce and distribute the article, including reprints, photographic reproductions, microform or any other reproductions of similar nature and translations, and includes the right to adapt the article for use in conjunction with computer systems and programs, including reproduction or publication in machine-readable form and incorporation in retrieval systems. Authors are responsible for obtaining from the copyright holder permission to reproduce any figures for which copyright exists.
Experimental procedures
All animal experiments should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, the European Communities Council Directive of 24 November 1986 (86/609/EEC) or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed.
Manuscripts should be accompanied by a statement that all efforts were made to minimise animal suffering, to reduce the number of animals used, and to utilise alternatives to in vivo techniques, if available.
Authors are advised to consult A fair press for animals [New Scientist (1992) 1816: 1830] before preparing their manuscript. The Editors reserve the right to reject papers if there is doubt whether suitable procedures have been used.
Style
Manuscripts, including references and figure legends, should be typed double-spaced on one side of A4 paper (206x294 cm) or equivalent, with margins no less than 2.5 cm. Type should be no smaller than 12 point. All typed pages should be numbered consecutively, starting with the title page . Either U.K. or U.S. spelling may be used, but must be consistent throughout.
Abbreviations. Abbreviations should be kept to a minimum. All abbreviations should be written in full when first used and the abbreviation given in parentheses.
Title page. This should contain a brief, but informative, title, a running title (not exceeding 40 characters), the names and addresses of the authors and a list of keywords or phrases. The author for correspondence, with telephone, Fax numbers and E-mail address, should be clearly indicated on this page. The manuscript should normally be produced using the following headings. One additional level of sub-headings may also be used.
Summary. The second page should consist of a short summary (not exceeding 200 words) which should be readily accessible to the non-specialist and contain the important points of the paper.
Keywords. Authors should provide up to six keywords, to appear just underneath the summary section. The keywords will be used for indexing purposes.
Introduction. The third page should start with a succinct account of why the work was performed. Long historical introductions should not be used. A statement accessible to a lay audience indicating the potential benefit of the work to man or animals should be included. If any of the work contained in the manuscript has been published previously in the form of an abstract this must be referenced.
Methods. Sufficient detail is required to enable others to repeat the experiments. Where animals are involved full descriptions of all analgesic, anaesthetic and surgical procedures must be stated. Where abbreviations are used in place of long chemical names the full chemical name should be provided in this section. Details of any statistical analyses performed should be given. SI units should be used.
Results. The results should be fully illustrated. Negative findings should also be noted to avoid unnecessary replication by others.
Discussion. This should be as concise as possible. Its main function should be to discuss the results in context with the current state of the field.
Acknowledgements. These should be as brief as courtesy allows.
References. These should not normally exceed 40. Davies, J., Francis, A. A., Jones, A. W., Watkins, J. C., 1981. 2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation. Neuroscience Letters 21, 77-81.
Ascher, P., Johnson, J. W. 1989., The NMDA receptor, its channel, and its modulation by glycine. In: Watkins, J. C., Collingridge, G. L., (Eds), The NMDA Receptor. IRL Press at Oxford University Press, Oxford, pp. 109-121.
Papers that have been accepted for publication may be cited as 'In press', and a photocopy of the manuscript must be provided. Papers submitted or in preparation should be referred to as (unpublished observations/personal communications) within the text, if absolutely necessary.
In the text, references should be given as: Smith (1964) or (Smith, 1964). In the case of multiple authorship, et al. should be used throughout, i.e. Smith et al. (1964). If works published by the same author(s) in the same year are cited, they should be distinguished by the letters a, b, c, etc.
The reference list must be arranged alphabetically according to the surname of the first author, and chronologically if several papers by the same author(s) are referenced.
Illustrations. For hard-copy submission manuscripts, two sets of figures in the form of high quality photographs, line drawings or laser prints should be sent to the Editorial Office together with the figure legends typed double-spaced on separate sheets. The figures should be lettered and clearly identified on the reverse with authors, figure numbers and orientation. Additional sets of figures should be included in the copies of the manuscript. These may be high quality photocopies and, where possible, the legend should be included with each figure (single-spaced if necessary) to aid the refereeing process.
All colour figures in accepted manuscripts will be charged at the rate of USD 300 for the first page of color per manuscript, followed by USD 200 for each subsequent page. Interactive Reports will be published on the web and in the print journal free of charge.
Tables. These should be kept to a minimum and should be self explanatory without reference to the text. Data presented in tables should not reproduce that presented in figures or the text.
A suitable location for the placement of tables and figures should be indicated in the text.
Proofs
For all accepted manuscripts, page proofs will be sent to the corresponding author (or the first-named author) for checking. Corrections to the proofs must be restricted to printer's errors. Any substantial alterations other than these may be charged to the author. Authors are particularly requested to return their corrected proofs as quickly as possible in order to facilitate rapid publication. Please note that authors are urged to check their proofs carefully before return, since late corrections cannot be guaranteed for inclusion in the printed journal. Reprints and copies of the issue (at a specially reduced rate) can be ordered on the form which will accompany the proofs. These should be returned to: Elsevier Ltd, Bampfylde Street, Exeter, EX1 2AH, U.K.
Editorial Board
Editor-in-Chief:
Graham L. Collingridge, Editorial Office, University of Bristol, Bristol BS8 1TD, UK Email: G.L.Collingridge@bristol.ac.uk
Editorial Assistant:
Rachel Ince Email: editor-neuropharmacology@bristol.ac.uk.
Editorial Board
Roger Anwyl, Dublin, Irelland
Nicholas M. Barnes, Birmingham
Ceri Davies, Harlow, Essex
Raymond Dingledine, Atlanta
Bertil Fredholm, Stockholm
John Garthwaite, London
Mark A. Geyer, La Jolla
Jean-Antoine Girault, Paris
A. Richard Green, Loughborough
P. Max Headley, Bristol
Ray Hill, Harlow
Daniel Hoyer, Basel
John T R Isaac, Bristol
Peter Jenner, London
Gavin Kilpatrick, Cambridge, England
Robin A.J. Lester, Birmingham, USA
David Lodge, Windlesham
Robert L. MacDonald, Nashville, USA
Robert Malenka, Palo Alto
Athina Markou, La Jolla
Charles A Marsden, Nottingham
Richard J. Miller, Chicago
Masayoshi Mishina, Tokyo
Stephen J Moss, London
Christopher G Parsons, Frankfurt
Gavril W. Pasternak, New York
Julian F R Paton, Bristol
Daniele Piomelli, Irvine
Michael W Quick, Los Angeles
Andrew D. Randall, Harlow
Klaus G Reymann, Magdeburg
Katherine W Roche, Bethesda
Michael A. Rogawski, Bethesda
nancy J Rothwell, Manchester
Darryle D Schoepp, Indianapolis
Peter H. Seeburg, Heidelberg
David R. Sibley, Bethesda
David N. Stephens, Brighton
Hiroyuki Sugiyama, Fukuoka
Stefano Vicini, Washington
|
